Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

State of play of pharmacogenetics and personalized medicine in heart failure.

Cardiovascular therapeutics - 1 Dec 2013

Parry Helen M, Doney Alex S F, Palmer Colin N A, Lang Chim C

Abstract excerpt

Heart failure is a common disease with high levels of morbidity and mortality. A large body of evidence guiding treatment shows prognostic benefit with beta-blockers and angiotensin-converting enzyme inhibitors, while diuretics are commonly prescribed for symptomatic benefit. Wide variation in drug response between clinically similar patients is a significant problem. Evidence suggests this may have a genetic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genome-Wide Association Study
Share to Heart Failure
Share to Nitric Oxide

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Pharmacogenetics

Share to Precision Medicine

Share to Receptors, Adrenergic, beta-1

Share to Receptors, Adrenergic, beta-2

Share to Renin-Angiotensin System

Source

Identifiers

PMID: 23480579
DOI: 10.1111/1755-5922.12030

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

State of play of pharmacogenetics and personalized medicine in heart failure.PMID 23480579Read ↗

The future of pharmacogenetics in the treatment of heart failure.Semantic proximity Read ↗

Pharmacogenetics of heart failure: evidence, opportunities, and challenges for cardiovascular pharmacogenomics.Semantic proximity Read ↗

Pharmacogenetics of heart failure.Semantic proximity Read ↗

Genetics and pharmacogenetics in heart failure.Semantic proximity Read ↗

Heart failure pharmacogenetics: past, present, and future.Semantic proximity Read ↗

Heart failure and personalized medicine.Semantic proximity Read ↗

Exploring the Role of Genetic and Genomic Factors in Therapeutic Response to Heart Failure: A Comprehensive Analytical ReviewSemantic proximity Read ↗

Pharmacogenetics in heart failure: how it will shape the future.Semantic proximity Read ↗

Genetic tailoring of pharmacotherapy in heart failure: optimize the old, while we wait for something new.Semantic proximity Read ↗

Pharmacogenomics of heart failure.Semantic proximity Read ↗

Mechanisms of pharmacogenomic effects of genetic variation within the cardiac adrenergic network in heart failure.Semantic proximity Read ↗

The emerging role of pharmacogenomics in the treatment of patients with heart failure.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.